CEO Transitions Create Risks for Australian Healthcare Investors -- Market Talk

Dow Jones
Jan 19

2341 GMT - RBC Capital Markets's message to investors in Australian healthcare stocks: Be alert to CEO transition risks. Among companies that have changed leaders in recent months are Ansell, Sonic Healthcare, Integral Diagnostics and Monash IVF. "The appointments of new CEOs follow long tenure periods under the previous management, and therefore we see possibilities for a combination of strategy resets, asset impairments, and 'kitchen sinking' guidance," says analyst Craig Wong-Pan. There could be operational disruptions from the management changes. Also, some managers who missed out on the CEO position could leave, RBC says. "We also note there have been a number of new CFOs, including at CSL, Ramsay Health Care and Healius," it adds. (david.winning@wsj.com; @dwinningWSJ)

 

(END) Dow Jones Newswires

January 18, 2026 18:41 ET (23:41 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10